Tag Archives: cardiovascular

World Heart Day 2015: Keeping Cardiovascular Health at the Heart of Our Mission

Today is World Heart Day, a day set aside each year to raise awareness of the risks of cardiovascular disease (CVD), and to take steps to help improve the heart health of individuals around the globe. But what does this mean to us at AstraZeneca? With over 100 years of cardiovascular (CV) experience, AstraZeneca continues to build a strong focus around CV health and the patients it impacts. This World Heart Day, we are sharing our efforts to offer resources that support heart health in a variety of ways. Through a cross-country tour of America that educated the public on cholesterol health, and programs that provide support and help patients access and afford their medicines, AstraZeneca works to strengthen our commitment to helping millions of CV patients worldwide.

This year we launched “Make Your Move Across America,” a national cholesterol education initiative that seeks to bring attention to one of the most common risk factors for developing heart disease – high cholesterol. Many people may not realize that heart disease is one of the leading causes of death, globally. By offering free cholesterol screenings to adults 18 and older at events across the United States, from state fairs to baseball games, Make Your Move Across America is providing the opportunity to learn more about your cholesterol numbers and how to work with your doctor to manage those numbers. More than 10,000 Americans have been screened to-date as a result of this initiative.

We feel it is important that CV patients understand what steps they can take to live a healthy life. AstraZeneca aims to meet this need with a patient support service that provides resources to help CV patients and caregivers from hospital discharge throughout the treatment journey. The free program offers important patient education and coaching in addition to savings offers, refill reminders, personal pharmacy locator, co-pay calculator, and coverage verification and information.

To support their ongoing care plan, patients also need access to the right medications. For the convenience of patients, AstraZeneca offers free home delivery of prescription hypertension (also known as high blood pressure) medicine to patients, a simpler way to meet patient needs.

AstraZeneca continually looks for ways to help patients not only access the care they need, but also help them more fully understand the importance of heart health. To us, World Heart Day serves as a reminder to continue to identify and meet the needs of CV patients and educate the community about actions they can take to reduce their risk of CVD.

World Heart Day: Our Opportunity to Make an Impact

By John Clymer, Executive Director, National Forum for Heart Disease & Stroke Prevention

John ClymerChances are you know somebody who has or may be at risk for cardiovascular disease. That’s because cardiovascular disease, which includes heart disease and stroke, is the number one cause of death, both in the United States and globally. The sad reality is that 1 in 3 Americans die from this disease each year, but the good news is there are ways to manage your risk.

This is why one day each year, September 29, is devoted to raising awareness about cardiovascular disease: World Heart Day. This observance, created by the World Heart Federation, is the world’s largest cardiovascular initiative. As a result, it provides the National Forum an opportunity to raise awareness and underscore the importance of managing one’s risk for cardiovascular disease and the factors that can cause it.

In celebration of World Heart Day 2015, we are proud to be working with our members to educate our communities on how to live healthier lives this fall. The AstraZeneca “Make Your Move Across America” initiative, a national cholesterol education campaign that offers free cholesterol screenings to adults 18 and older in select cities across the country, is an activity we are proud to be a part of this World Heart Day. Make Your Move Across America provides adults an opportunity to learn their cholesterol numbers and how to work with their doctor to manage them if necessary, which are critical components to reducing a person’s risk for heart disease and stroke. I encourage you to visit the campaign’s website and join the cholesterol conversation on Twitter using the hashtag #LetsTalkLipids.

Let’s celebrate World Heart Day by putting our cardiovascular health first. Take a moment to speak with your doctor about what you can do to manage your cholesterol so you can make smart choices for your cardiovascular health this year and every year!

 

Do you know your numbers?

An estimated 71 million American adults, representing 34 percent of the population, have high LDL-C or “bad cholesterol” levels – a major risk factor for cardiovascular disease. Unfortunately, many Americans don’t know that they have high cholesterol because there are usually no signs or symptoms. However, a simple blood test – also known as a lipid profile blood test – can help to determine your levels and is part of a larger cardiac risk assessment.

Cholesterol Fast Facts

About John Clymer

John Clymer is executive director of the National Forum for Heart Disease & Stroke Prevention, an independent, nonprofit catalyst for collaboration.  Additionally, he is an adjunct assistant professor at Loma Linda University School of Public Health, guest lecturer at Johns Hopkins Bloomberg School of Public Health, and member of the US Community Preventive Services Task Force.

3163023 Last Updated 8/15

February is Heart Month: Show Some Love for Yourself & Loved Ones

During February, hearts are everywhere—Valentine’s cards, decorations, and commercials are filled with red hearts and messages of love. But February is about more than just greetings cards; it’s also the American Heart Association’s American Heart Month, a time to show your heart some love. Learn about the risks for heart disease and take action so you and your loved ones can stay heart healthy.

Cardiovascular disease, including high blood pressure and heart disease, are the number one killers of men and women in the United States today.

Understand Your Risk

Cardiovascular disease affects people differently. Men are more than twice as likely as women to die from cardiovascular disease. Race and ethnicity also play a role; African Americans are more likely than any other racial or ethnic group to have high blood pressure and develop heart disease later in life. Having a close relative with heart disease means you are at a higher risk of developing cardiovascular disease too.

Check Your Health

Mark your calendar this February, to not only send love on Valentine’s Day, but also to give yourself a little bit of love, following these tips and information towards your heart health. Schedule a yearly visit with your doctor to test your risk for high blood pressure and diabetes, conditions that can often go unnoticed without a medical check-up. While you’re there, get a blood panel done to check your cholesterol and triglyceride levels, indicators of serious cardiovascular disease.

Lifestyle Changes

If your New Year’s resolution was to work towards a healthier lifestyle—and you haven’t done it yet—Heart Month is a great time to get back on track. Use February to kick start a heart healthy routine and incorporate simple daily habits into your lifestyle:

  • Diet: Incorporate more fruits and vegetables into your diet in place of processed or fatty foods.
  • Exercise: Try to do some physical activity every day. A nightly walk, morning bike ride, or simply taking the stairs more often can help your heart health.
  • Stop Smoking: Work with a support group and your doctor to stop smoking and improve your overall health.
  • Partner Up: Joining forces with a friend can go a long way in helping you become more heart healthy. Exercise with your buddy, share healthy recipes, and encourage each other to stay on track towards your goals.

Follow Us Online

AstraZeneca has been dedicated to addressing cardiovascular disease for over 100 years, and our vision for the future is to continue this legacy of delivering effective patient education and valuable new medicines to patients through scientific research, innovation, and excellence.

AstraZeneca encourages you to consider Heart Month as an opportunity to remind friends and family to encourage one another to keep a healthy heart. Check back on our blog throughout the month, and follow us on Twitter, and Facebook for heart healthy tips and facts.

This February, take the time to care for yourself and stay heart healthy.

The Latest in Science & Technology Come Together at AHA 2014

AHA 2014Medical congresses present an important opportunity for the science and medical community to come together and participate in the open exchange and dialogue around the latest science for a particular therapeutic area (TA). The 2014 American Heart Association Scientific Sessions (AHA ‘14) are no different.

Taking place this year in Chicago, IL from November 15–19, AHA is recognized as the leading cardiovascular (CV) congress in the US with a strong global presence, attracting attendees from more than 100 countries.

For companies like AstraZeneca, attending and having a leadership presence at AHA ‘14 is fundamental to our business as it helps us better understand our customers, the market and evolving science in CV and metabolic disease (CVMD). As a company that leads the way in the clinical research of lipid and platelet biology, AHA ‘14 also gives us the chance to participate in the scientific discussions around these key areas that add to the body of evidence in cardiovascular disease (CVD). As research presented at AHA tends to demonstrate, there is still a tremendous unmet need in the management of at-risk patients with risk factors for CVD, and AstraZeneca remains committed to these patients to ensure they are informed about our broad portfolio of CVMD medicines.

Worldwide, more than 17 million patients suffer or die from CVMD each year; therefore it’s important that we continue to follow the science around these intertwined diseases in the interest of the patients we ultimately serve.

“AstraZeneca has a long-standing commitment to improving patient health through scientific excellence in CVMD,” said Paul Spittle, Vice President, Cardiovascular & Respiratory, AstraZeneca. “With a 100-year legacy in this space, our singular CVMD presence at AHA ‘14 will tell a unified story around the science and innovation behind our medicines in this key therapy area.”

Paul Spittle, Vice President, Cardiovascular & Respiratory, AstraZeneca

Paul Spittle, Vice President, Cardiovascular & Respiratory, AstraZeneca

The AstraZeneca booth at this year’s meeting offers healthcare professionals an opportunity to interact with the latest information about our medicines and ongoing clinical research. Each section of the booth will incorporate innovative technology to tell a compelling clinical story.

Building on the themes of technology and innovation, AstraZeneca has developed the official meeting iPad application (app), Conference Notes, a novel tool that promotes scientific exchange and will help delegates get the most out of medical conferences. This iPad app allows attendees to plan their schedules in advance, bookmark and take notes on key slides and store presentations for future reference.

Join the conversation online using #AHA14 and follow @AstraZenecaUS on Twitter for updates throughout the congress.

AZ Sponsors Cholesterol Screening at Homestead-Miami Speedway During NASCAR Championship Races

By Rod Wooten, Commercial Brand Leader

Cholesterol may not be on the minds of NASCAR fans in November as they are focused on the thrill of watching the best drivers in the sport during the championship races. For heart specialists worldwide, however, November is synonymous with the gathering of top researchers in heart disease during the American Heart Association (AHA) Scientific Sessions.

This year, AstraZeneca is excited to bring free cholesterol screenings to adult NASCAR fans during the Ford Championship Weekend at the Homestead-Miami Speedway, November 14-16.

High cholesterol (total cholesterol ≥ 240 mg/dL) affects an estimated 31.9 million American adults. Yet, only 1 out of every 3 adults with high cholesterol has the condition under control. Because high cholesterol has no signs or symptoms, a blood test is the only way to find out if you have high cholesterol or are at risk for it.

AstraZeneca has been driving cardiovascular innovation for 100 years. Today, we remain committed to pushing the boundaries of science and educating patients about major cardiovascular risk factors, including high cholesterol.

The cholesterol screenings will be open to all interested adults (age 18 and older) attending the Championship who visit Homestead-Miami Speedway. Visitors will also have the opportunity to speak with an onsite healthcare professional regarding their cholesterol screening results and the importance of healthy cholesterol levels.

AstraZeneca is pleased to bring free cholesterol screenings to adults in the Homestead-Miami area, and encourages all adults to learn more about their cholesterol health.

3061514 Last Updated 11/14

AZ Employees Go Red for the American Heart Association

AstraZeneca is committed to supporting organizations that address the issues impacting patients and their families. On May 9, several AstraZeneca employees, decked in bright red accessories, attended the American Heart Association’s (AHA) 11th Annual Philadelphia Go Red for Women Luncheon. AstraZeneca was proud to sponsor the event, which featured a health expo, silent auction, health screenings, a Heart Healthy Lunch and plenty of time to network and mingle with prominent business executives, community leaders, healthcare professionals and volunteers. Guests could also pledge a personal commitment with Open Your Heart, a commemorative donating opportunity, and further contribute to AHA’s education and research efforts.

Front Row (left to right):  Michelle Benfield,  Kim Guillen, Angelina Smolskis Back Row (left to right):  Lydia Hallgren, Chris Espositio, Lindsay Adair Gehret, Lauren Mucci

Front Row (left to right): Michelle Benfield, Kim Guillen, Angelina Smolskis
Back Row (left to right): Lydia Hallgren, Chris Espositio, Lindsay Adair Gehret, Lauren Mucci

Volunteer champion Krista Willis Savino highlighted the strength and mission of AHA by sharing her story. Upon birth, she was diagnosed with Ebstein’s anomaly, a rare congenital heart defect that affects less than 200,000 people in the U.S. Doctors predicted she may not live to leave the hospital or, under best circumstances, past the age of two. However, the future brightened for Krista. Advances in research and medical treatments within Krista’s own lifetime changed everything. Krista, now 28 years old and recently married, has undergone numerous operations but lives a happy, healthy and physically active life.

AHA strives to build healthier lives, free of cardiovascular diseases and stroke, and centers all actions around this mission. With unifying values, AstraZeneca continues to sponsor and support AHA locally and nationally in various efforts and initiatives including Go Red for Women, the Heart Ball, the Heart Walk and CPR Anytime Training. Visit heart.org to learn more about cardiovascular disease and related conditions, and how you can join the cause.

MedStar Official Addresses Importance of ACC Patient Navigator Program

By Dr. Stuart F. Seides, Physician Executive Director at MedStar Heart Institute

From left: Dr. Allen Taylor, Chief of Cardiology at MedStar Heart Institute; Rich Buckley, VP Corporate Affairs North America, AstraZeneca; Shal Jacobovitz, CEO of the American College of Cardiology; Dr. Stuart Seides, Chief Executive at MedStar Heart Institute

From left: Dr. Allen Taylor, Chief of Cardiology at MedStar Heart Institute; Rich Buckley, VP Corporate Affairs North America, AstraZeneca; Shal Jacobovitz, CEO of the American College of Cardiology; Dr. Stuart Seides, Chief Executive at MedStar Heart Institute

As the Physician Executive Director at MedStar Heart Institute in Washington, D.C., it is my responsibility to ensure that we provide patients with the best in cardiac care. From the moment patients arrive, through their treatment, discharge and then follow-up care—the MedStar Heart Institute strives to provide a seamless continuum of services.

Several weeks ago, I attended an event at MedStar Washington Hospital Center to celebrate the launch of the American College of Cardiology (ACC) Patient Navigator Program, sponsored by AstraZeneca. The program provides personalized support to heart attack and heart failure patients as they transition from hospital to home, which is vital because cardiovascular disease impacts every patient differently.

The ACC Patient Navigator Program truly puts cardiovascular patients and their caregivers first as they discharge from the hospital—a process that can be confusing and overwhelming for many. I commend the ACC and AstraZeneca for working together to bring this innovative program to my hospital, and I look forward to sharing the results with my peers.

Dr. Stuart F. Seides is the Physician Executive Director at MedStar Heart Institute, one of the highest volume heart care programs in the United States. Dr. Seides is an interventional cardiologist, practicing in Washington, D.C. since 1978.

PNP Logo Graphic

MedStar Logo

Listen to Your Heart

February is Heart Month

February marks American Heart Month—a time dedicated to raising awareness of heart disease, the leading cause of death in the United States. Heart disease, also referred to as cardiovascular disease, is a term used to describe numerous problems, many of which can be attributed to atherosclerosis, a condition in which plaque builds up in the walls of the arteries slowly over time. Atherosclerosis can lead to narrowing of arteries and reduction in proper blood flow to the heart muscle.

Over the past decade, the death rate from heart disease has fallen about 39 percent in the United States, but according to the American Heart Association (AHA), the burden of the disease and number of patients with risk factors remains alarmingly high. The AHA recently released its 2014 report on cardiovascular disease in America, which revealed:

  • Nearly 380,000 people die each year from heart disease, meaning it remains the number one cause of death in the United States. In fact, someone in the United States dies from heart disease about every 40 seconds
  • In the United States, direct and indirect costs of cardiovascular disease total about $315.4 billion
  • An estimated 31.9 million American adults (13.8%) have high total cholesterol levels—a major risk factor for atherosclerosis. Even more—71 million American adults—have high levels of LDL (“bad”) cholesterol
  • Approximately 27% of American adults have high levels of triglycerides—a type of fat found in the blood that is associated with cardiovascular disease

It’s also worth noting that heart disease doesn’t discriminate in men or women. With all of this in mind, AstraZeneca encourages you to consider Heart Month as an opportunity to remind family, friends and colleagues to focus on ways to keep a healthy heart. Begin by visiting our company’s Twitter and Facebook pages this month, where we will be posting photos like the one above for you to share, use the hashtag #HeartMonth and write why you keep a healthy heart. Here are a few healthy tips to consider:

  • Replace processed snacks with fresh fruit and vegetables
  • Avoid foods that contain high levels of saturated and trans fat and opt for nutrient-rich foods that contain vitamins, minerals and fiber
  • Moderate your intake of alcohol and do not smoke
  • Identify relaxing activities that help you to de-stress at the end of every day
  • Know your numbers by monitoring your weight, blood pressure and cholesterol/triglyceride levels
  • Talk to your doctor about your potential risk factors for heart disease and how you can work to manage them to strive for a healthy heart

For more information on heart disease, visit the American Heart Association Web site or American College of Cardiology CardioSmart resource center.

At AstraZeneca, we are committed to the development of new medicines to address the world’s most critical unmet medical needs. AstraZeneca has decades of cardiovascular (CV) experience, and our vision for the future is to continue this legacy of delivering great medicines to patients through scientific research, innovation, and excellence. We also remain committed to helping address unmet needs for health care providers, patients and caregivers affected by cardiovascular diseases.

2939101 Last Updated 1/14